Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni and ribavirin in treatment-naive chronic HCV genotype 3
NCT02413593Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2015
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir in Hepatitis C, genotype 3, sponsored by Gilead Sciences. Started Apr 2015; status: completed.
02
Drugs
ledipasvir
03
Conditions
Hepatitis C, genotype 3
Beyond the preview
Go deeper on NCT02413593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02413593.